Trident Texofab Ltd (540726) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 540726 | NSE: | Textile | Small Cap

Trident Texofab Share Price

242.05 -0.45 -0.19%
as on 16-Dec'25 09:24

DeciZen - make an informed investing decision on Trident Texofab

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Trident Texofab stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
123.06
Market Cap:
363.7 Cr.
52-wk low:
146.3
52-wk high:
379

Is Trident Texofab Ltd an attractive stock to invest in?

1. Is Trident Texofab Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Trident Texofab Ltd is a below average quality company.

2. Is Trident Texofab Ltd undervalued or overvalued?

The key valuation ratios of Trident Texofab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Trident Texofab Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Trident Texofab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Trident Texofab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Trident Texofab Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 9.9%15.9%16.1%13.1%14.3%9.8%9%13.1%10.3%11.4%-
Value Creation
Index
-0.30.10.2-0.10.0-0.3-0.4-0.1-0.3-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 667685.586.99149.984.396.499.5122129
Sales YoY Gr.-15.1%12.5%1.7%4.7%-45.1%68.9%14.3%3.2%22.7%-
Adj EPS 2.640.61.210.30.92.30.90.72
YoY Gr.-57%-84.1%90.6%-21.3%-69.8%220.7%146.2%-62.9%-22.4%-
BVPS (₹) 43.547.68.61111.811.912.815.116.131.837.9
Adj Net
Profit
0.20.30.61.20.90.30.92.30.90.93
Cash Flow from Ops. 0.70.1-2.5-2.8-2.921.45.92.7-13.7-
Debt/CF from Ops. 4.341.1-2.1-5.4-7.815.925.65.913.6-1.9-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.1%6.1%13.1%22.7%
Adj EPS -14%-7.2%-10.8%-22.4%
BVPS-3.4%22%35.3%97%
Share Price - 51.6% 36.3% 61.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
5.98.810.212.28.22.57.516.45.52.85.7
Op. Profit
Mgn %
1.51.51.72.85.35.85.76.66.34.66.4
Net Profit
Mgn %
0.30.40.71.410.61.12.40.90.72.3
Debt to
Equity
0.91.40.61.41.92.62.82.32.30.60.2
Working Cap
Days
173136126152147304185176194196106
Cash Conv.
Cycle
223182961136989810510951

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 13.14%

Debt to equity has declined versus last 3 years average to 0.62

Sales growth is good in last 4 quarters at 22.36%

Return on Equity has declined versus last 3 years average to 5.70%

Net Profit has been subdued in last 3 years -10.80%

Latest Financials - Trident Texofab Ltd.

Standalone Consolidated
TTM EPS (₹) 2 -
TTM Sales (₹ Cr.) 129 -
BVPS (₹.) 37.9 -
Reserves (₹ Cr.) 42 -
P/BV 6.39 -
PE 123.06 -
From the Market
52 Week Low / High (₹) 146.25 / 379.00
All Time Low / High (₹) 13.33 / 379.00
Market Cap (₹ Cr.) 364
Equity (₹ Cr.) 15
Face Value (₹) 10
Industry PE 33.4

Management X-Ray of Trident Texofab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Trident Texofab - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Trident Texofab

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales667685879150849699122
Operating Expenses 657584848647809093116
Manufacturing Costs0001212334
Material Costs637282807942728084106
Employee Cost 1112222222
Other Costs 1113324445
Operating Profit 1112535666
Operating Profit Margin (%) 1.5%1.5%1.7%2.8%5.3%5.8%5.7%6.5%6.3%4.6%
Other Income 0000021203
Interest 1111333445
Depreciation 0000111222
Exceptional Items -0-000-000-000
Profit Before Tax 0112211313
Tax 0000110100
Profit After Tax 0011101213
PAT Margin (%) 0.1%0.4%0.9%1.5%1.0%0.7%1.2%2.3%1.1%2.1%
Adjusted EPS (₹)0.10.50.81.30.90.41.02.21.11.9
Dividend Payout Ratio (%)0%0%53%31%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 34811121213151643
Share Capital 004441010101014
Reserves 33477235630
Minority Interest0000000000
Debt35413202933323424
Long Term Debt154911192019187
Short Term Debt2004101013131616
Trade Payables31153019161611181715
Others Liabilities 112481013131519
Total Liabilities 382445475668717782101

Fixed Assets

Gross Block2223141725292828
Accumulated Depreciation0011234578
Net Fixed Assets 1122121422232220
CWIP 0006094000
Investments 0131122442
Inventories92541087111416
Trade Receivables26153229263031343741
Cash Equivalents 0200000003
Others Assets 13335456619
Total Assets 382445475668717782101

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 10-2-3-32163-14
PBT 0112211313
Adjustment 0001435464
Changes in Working Capital 1-0-3-5-8-2-5-1-4-20
Tax Paid -0-0-0-1-1-00-0-0-0
Cash Flow From Investing Activity -0-1-2-7-2-10-40-14
Capex 0-0-0-8-2-10-4-0-00
Net Investments -0-0-21-1-0-1-0-04
Others -00-0-00-0-01-00
Cash Flow From Financing Activity -12310583-6-212
Net Proceeds from Shares 00420000053
Net Proceeds from Borrowing -15-15291-3-1-10
Interest Paid 000-1-2-3-2-3-4-4
Dividend Paid 000-0-000000
Others 0-2-0362403-26
Net Cash Flow -02-20-0-00003

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)1.79.0712.4413.568.253.047.9115.86.888.46
ROCE (%)9.8715.916.113.1214.289.88.9513.0710.3211.43
Asset Turnover Ratio1.992.432.5521.870.821.221.311.261.35
PAT to CFO Conversion(x)N/AN/A-2-3-3N/A133-4.67
Working Capital Days
Receivable Days12410098122106206132122128115
Inventory Days44281518276633344444
Payable Days1491151011148214070667554

Trident Texofab Ltd Stock News

Trident Texofab Ltd FAQs

The current trading price of Trident Texofab on 16-Dec-2025 09:24 is ₹242.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Dec-2025 the market cap of Trident Texofab stood at ₹363.6.
The latest P/E ratio of Trident Texofab as of 15-Dec-2025 is 123.1.
The latest P/B ratio of Trident Texofab as of 15-Dec-2025 is 6.39.
The 52-week high of Trident Texofab is ₹379.0 and the 52-week low is ₹146.2.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Trident Texofab is ₹128.6 ( Cr.) .

About Trident Texofab Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×